Literature DB >> 2903189

Vasovagal reactions to cardiovascular drugs: the first dose effect.

P F Semple1, P Thorén, A F Lever.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 2903189     DOI： 10.1097/00004872-198808000-00001

Source DB:  PubMed          Journal:  J Hypertens        ISSN： 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  7 in total

1.  'First dose' hypotension and venodilatation.

Authors:  S Capewell; A Capewell
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

Review 2.  Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

3.  Captopril in congestive cardiac failure.

Authors:  D J Webb; J R Cockcroft
Journal:  BMJ       Date:  1989-11-18

Review 4.  Optimal dosage of ACE inhibitors in older patients.

Authors:  B Tomlinson
Journal:  Drugs Aging       Date:  1996-10       Impact factor: 3.923

Review 5.  Long-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials?

Authors:  M P Sambhi; H Gavras; J I Robertson; W M Smith
Journal:  West J Med       Date:  1993-03

6.  Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br Heart J       Date:  1991-09

7.  The response to the first dose of an angiotensin converting enzyme inhibitor in uncomplicated hypertension--a placebo controlled study utilising ambulatory blood pressure recording.

Authors:  R J MacFadyen; A D Bainbridge; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.